|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent Provention Bio insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why Provention Bio insider buys are important for investors to follow.
Date | Insider | Price | Amount |
12-3-2021 Insider Buy |
Eleanor Ramos Chief Medical Officer |
$6.49
CAGR »
|
$33,764.89 5,201 shares |
11-30-2021 Insider Buy |
Ashleigh Palmer Director and CEO |
$6.66
CAGR »
|
$24,990.00 3,750 shares |
11-24-2021 Insider Buy |
Francisco Leon Chief Scientific Officer |
$7.24
CAGR »
|
$40,187.55 5,550 shares |
9-2-2020 Insider Buy |
Eleanor Ramos Chief Medical Officer |
$12.06
CAGR »
|
$3,605.94 299 shares |
9-2-2020 Insider Buy |
Andrew T. Drechsler Chief Financial Officer |
$11.72
CAGR »
|
$23,440.00 2,000 shares |
8-21-2020 Insider Buy |
Francisco Leon Chief Scientific Officer |
$13.35
CAGR »
|
$26,708.00 2,000 shares |
8-20-2020 Insider Buy |
Eleanor Ramos Chief Medical Officer |
$13.23
CAGR »
|
$33,075.00 2,500 shares |
8-18-2020 Insider Buy |
Ashleigh Palmer President and CEO |
$12.69
CAGR »
|
$6,345.00 500 shares |
8-17-2020 Insider Buy |
Ashleigh Palmer President and CEO |
$12.83
CAGR »
|
$35,924.00 2,800 shares |
8-13-2020 Insider Buy |
Andrew T. Drechsler Chief Financial Officer |
$13.01
CAGR »
|
$22,767.50 1,750 shares |
6-24-2020 Insider Buy |
Francisco Leon Chief Scientific Officer |
$15.43
CAGR »
|
$30,862.00 2,000 shares |
3-19-2020 Insider Buy |
Jason Hoitt Chief Commercial Officer |
$5.43
CAGR »
|
$24,435.00 4,500 shares |
3-19-2020 Insider Buy |
Francisco Leon Chief Scientific Officer |
$5.92
CAGR »
|
$59,200.00 10,000 shares |
12-20-2019 Insider Buy |
Ashleigh Palmer President and CEO |
$11.39
CAGR »
|
$23,634.25 2,075 shares |
12-26-2019 Insider Buy |
Eleanor Ramos CMO & COO |
$14.34
CAGR »
|
$28,680.00 2,000 shares |
12-16-2019 Insider Buy |
Francisco Leon Chief Scientific Officer |
$11.92
CAGR »
|
$23,840.00 2,000 shares |
9-30-2019 Insider Buy |
Anthony Digiandomenico Director |
$6.83
CAGR »
|
$204,900.00 30,000 shares |
9-30-2019 Insider Buy |
Francisco Leon Chief Scientific Officer |
$7.67
CAGR »
|
$11,121.50 1,450 shares |
9-26-2019 Insider Buy |
Anthony Digiandomenico Director |
$8.44
CAGR »
|
$42,200.00 5,000 shares |
9-25-2019 Insider Buy |
Anthony Digiandomenico Director |
$8.39
CAGR »
|
$41,950.00 5,000 shares |
9-24-2019 Insider Buy |
Ashleigh Palmer President and CEO |
$8.38
CAGR »
|
$25,140.00 3,000 shares |
8-8-2019 Insider Buy |
Ashleigh Palmer President and CEO |
$9.15
CAGR »
|
$96,990.00 10,600 shares |
8-8-2019 Insider Buy |
Francisco Leon Chief Scientific Officer |
$9.09
CAGR »
|
$22,725.00 2,500 shares |
8-8-2019 Insider Buy |
Anthony Digiandomenico Director |
$9.09
CAGR »
|
$90,900.00 10,000 shares |
6-20-2019 Insider Buy |
Anthony Digiandomenico Director |
$10.96
CAGR »
|
$109,600.00 10,000 shares |
6-18-2019 Insider Buy |
Anthony Digiandomenico Director |
$10.88
CAGR »
|
$108,800.00 10,000 shares |
6-18-2019 Insider Buy |
Ashleigh Palmer President and CEO |
$10.83
CAGR »
|
$43,320.00 4,000 shares |
6-18-2019 Insider Buy |
Anthony Digiandomenico Director |
$10.88
CAGR »
|
$108,800.00 10,000 shares |
6-18-2019 Insider Buy |
Ashleigh Palmer President and CEO |
$10.83
CAGR »
|
$43,320.00 4,000 shares |
6-17-2019 Insider Buy |
Anthony Digiandomenico Director |
$12.16
CAGR »
|
$304,000.00 25,000 shares |
12-28-2018 Insider Buy |
Wayne Pisano Director |
$1.80
CAGR »
|
$9,000.00 5,000 shares |
12-28-2018 Insider Buy |
Anthony Digiandomenico Director |
$1.76
CAGR »
|
$17,600.00 10,000 shares |
12-31-2018 Insider Buy |
Ashleigh Palmer President and CEO |
$1.71
CAGR »
|
$9,953.50 5,825 shares |
12-28-2018 Insider Buy |
Anthony Digiandomenico Director |
$1.76
CAGR »
|
$17,600.00 10,000 shares |
12-27-2018 Insider Buy |
Anthony Digiandomenico Director |
$1.95
CAGR »
|
$39,000.00 20,000 shares |
12-26-2018 Insider Buy |
Avery W. Catlin Director |
$1.88
CAGR »
|
$18,750.00 10,000 shares |
12-24-2018 Insider Buy |
Anthony Digiandomenico Director |
$1.92
CAGR »
|
$33,158.40 17,270 shares |
12-21-2018 Insider Buy |
Anthony Digiandomenico Director |
$1.85
CAGR »
|
$3,700.00 2,000 shares |
12-20-2018 Insider Buy |
Anthony Digiandomenico Director |
$1.96
CAGR »
|
$9,800.00 5,000 shares |
12-3-2018 Insider Buy |
Anthony Digiandomenico Director |
$2.45
CAGR »
|
$10,882.90 4,442 shares |
11-30-2018 Insider Buy |
Anthony Digiandomenico Director |
$2.45
CAGR »
|
$12,253.02 5,000 shares |
11-27-2018 Insider Buy |
Anthony Digiandomenico Director |
$2.46
CAGR »
|
$24,600.00 10,000 shares |
11-26-2018 Insider Buy |
Anthony Digiandomenico Director |
$2.65
CAGR »
|
$26,500.00 10,000 shares |
11-9-2018 Insider Buy |
Avery W. Catlin Director |
$3.15
CAGR »
|
$31,500.00 10,000 shares |
7-19-2018 Insider Buy |
Peter A. Appel >10% Owner |
$4.00
CAGR »
|
$3,000,000.00 750,000 shares |
7-19-2018 Insider Buy |
Eleanor Ramos Chief Medical Officer & COO |
$4.00
CAGR »
|
$240,000.00 60,000 shares |
7-19-2018 Insider Buy |
Andrew T. Drechsler Chief Financial Officer |
$4.00
CAGR »
|
$25,000.00 6,250 shares |
7-19-2018 Insider Buy |
Francisco Leon Chief Scientific Officer |
$4.00
CAGR »
|
$150,000.00 37,500 shares |
7-19-2018 Insider Buy |
Ashleigh Palmer President and CEO |
$4.00
CAGR »
|
$150,000.00 37,500 shares |
7-19-2018 Insider Buy |
Wayne Pisano Director |
$4.00
CAGR »
|
$10,000.00 2,500 shares |
Also See: Institutional Holders of PRVB
Also See: SEC filings
Below we present the annualized performance delivered by Provention Bio stock since 12-3-2021 (the date of the most recent
insider purchase). The performance of the investment from the time Provention Bio insider buying occurred is the ultimate
test of whether insiders were right about PRVB being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
12/06/2021 |
|
End date: |
04/27/2023 |
|
Start price/share: |
$6.29 |
|
End price/share: |
$24.98 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
297.14% |
|
Average Annual Total Return: |
170.42% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$39,713.30 |
|
Years: |
1.39 |
|
Provention Bio Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent Provention Bio insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding PRVB
|
|